Publication | Closed Access

Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction

Dose-finding StudyThrombosisCardiovascular DiseaseMedicineAnticoagulantPharmacotherapyPlatelet AntagonistPharmacologyDouble BolusCardiologyDrug DiscoveryAcute Myocardial InfarctionMyocardial Infarction